Striant

   
Google
 
Web NewDrugInformation.com

Striant


Drug - Striant
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; BUCCAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Testosterone
Multiple ingredients are in alphabetical order.

Strength - 30MG
The potency of the active ingredient(s), Testosterone. May repeat for multiple part products.

Applicant - COLUMBIA LABS
The firm name holding legal responsibility for Striant. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021543
The FDA assigned number to Striant. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Striant. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 19, 2003
The date Striant was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Striant. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Striant is in. Format is RX, OTC, DISCN.

Applicant Full Name - Columbia Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Striant.

Striant